Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Product revenue $ 2,956 $ 3,378 $ 8,793 $ 11,574
Costs of revenue 1,408 765 2,791 2,675
Gross profit 1,548 2,613 6,002 8,899
Operating expenses:        
Research and development 1,433 1,582 3,790 4,743
General and administrative 1,092 1,912 3,288 4,834
Sales and marketing 1,579 2,326 5,005 7,514
Total operating expenses 4,104 5,820 12,083 17,091
Loss from operations (2,556) (3,207) (6,081) (8,192)
Other income (expenses):        
Interest expense (270) (745) (1,008) (3,998)
Loss on extinguishment of debt (417) (661)
Change in fair value of derivative liabilities 756 (252) 2,938 (228)
Offering costs (571) (131) (571)
Other income 1 5 (2) 11
Total other income (expense), net 487 (1,980) 1,797 (5,447)
Net loss before income taxes (2,069) (5,187) (4,284) (13,639)
Provision for income taxes
Net loss (2,069) (5,187) (4,284) (13,639)
Deemed dividend related to beneficial conversion feature and accretion of a discount on Series A Preferred Stock (6,278) (6,278)
Net loss attributable to common stockholders $ (2,069) $ (11,465) $ (4,284) $ (19,917)
Net loss per share        
Basic and diluted $ (0.68) $ (5.97) $ (1.47) $ (15.21)
Weighted average common shares outstanding:        
Basic and diluted 3,022,073 1,920,745 2,918,240 1,309,286